<![CDATA[SpeeDx Pty. Ltd. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=32521>Tue, 07 Apr 2026 07:15:46 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[SpeeDx Build Further Coverage in SARS-CoV-2 Genotyping Reagent Portfolio]]>https://www.newswire.co.kr/newsRead.php?no=931785Thu, 07 Oct 2021 14:10:00 +0900<![CDATA[스피덱스, 제2형 중증급성호흡기증후군 코로나19 유전형 시약 포트폴리오의 적용 범위 확대]]>https://www.newswire.co.kr/newsRead.php?no=931786Thu, 07 Oct 2021 14:10:00 +0900<![CDATA[SpeeDx and SynGenis Partner for Custom Oligonucleotide Synthesis]]>https://www.newswire.co.kr/newsRead.php?no=931219Wed, 29 Sep 2021 10:05:00 +0900<![CDATA[스피덱스, 맞춤형 올리고 뉴클레오타이드 합성 위해 신제니스와 제휴]]>https://www.newswire.co.kr/newsRead.php?no=931220Wed, 29 Sep 2021 10:05:00 +0900<![CDATA[SpeeDx Expand SARS-CoV-2 Variant Analysis Pipeline]]>https://www.newswire.co.kr/newsRead.php?no=928863Wed, 18 Aug 2021 11:00:00 +0900<![CDATA[스피덱스, SARS-CoV-2 변이 분석 파이프라인 확대]]>https://www.newswire.co.kr/newsRead.php?no=928864Wed, 18 Aug 2021 11:00:00 +0900<![CDATA[SpeeDx Receives Clearance for COVID-19 Diagnostic Test]]>https://www.newswire.co.kr/newsRead.php?no=928678Thu, 12 Aug 2021 17:30:00 +0900<![CDATA[스피덱스, 코로나19 진단 테스트 승인]]>https://www.newswire.co.kr/newsRead.php?no=928679Thu, 12 Aug 2021 17:30:00 +0900<![CDATA[SpeeDx Launch Solution for SARS-CoV-2 Variant Analysis]]>https://www.newswire.co.kr/newsRead.php?no=927771Tue, 27 Jul 2021 13:45:00 +0900<![CDATA[스피덱스, SARS-CoV-2 변종 분석 솔루션 출시]]>https://www.newswire.co.kr/newsRead.php?no=927772Tue, 27 Jul 2021 13:45:00 +0900<![CDATA[SpeeDx and MolGen Announce Partnership for COVID-19 Test Solution]]>https://www.newswire.co.kr/newsRead.php?no=926413Thu, 01 Jul 2021 15:50:00 +0900<![CDATA[스피덱스와 몰젠, 코로나19 검사 솔루션 위한 파트너십 발표]]>https://www.newswire.co.kr/newsRead.php?no=926414Thu, 01 Jul 2021 15:50:00 +0900<![CDATA[SpeeDx Receives CARB-X Funding to Develop Rapid Point-of-Care Diagnostic]]>https://www.newswire.co.kr/newsRead.php?no=923125Tue, 11 May 2021 14:00:00 +0900<![CDATA[스피덱스, 카브 엑스로부터 180만달러 지원 확보]]>https://www.newswire.co.kr/newsRead.php?no=923128Tue, 11 May 2021 14:00:00 +0900<![CDATA[SpeeDx Receives CE-IVD Mark for PlexPCR® SARS-CoV-2]]>https://www.newswire.co.kr/newsRead.php?no=922267Tue, 27 Apr 2021 10:20:00 +0900<![CDATA[스피덱스, PlexPCR® SARS-CoV-2에 대한 CE-IVD 마크 획득]]>https://www.newswire.co.kr/newsRead.php?no=922268Tue, 27 Apr 2021 10:20:00 +0900<![CDATA[SpeeDx Increase Distribution Network]]>https://www.newswire.co.kr/newsRead.php?no=920274Fri, 19 Mar 2021 11:05:00 +0900<![CDATA[스피덱스, 자사의 테스트제품에 대한 유통망 대폭 넓혀]]>https://www.newswire.co.kr/newsRead.php?no=920275Fri, 19 Mar 2021 11:05:00 +0900<![CDATA[SpeeDx Partners with Nepean Hospital to Commercialise Respiratory Virus Host Biomarker Assay]]>https://www.newswire.co.kr/newsRead.php?no=913783Tue, 10 Nov 2020 13:35:00 +0900<![CDATA[스피덱스, 네핀 병원과 제휴해 호흡기 바이러스 숙주 바이오마커 분석 상용화 추진]]>https://www.newswire.co.kr/newsRead.php?no=913786Tue, 10 Nov 2020 13:35:00 +0900<![CDATA[SpeeDx and Nepean Hospital Awarded Federal Funding for Viral Respiratory Biomarker Test]]>https://www.newswire.co.kr/newsRead.php?no=910149Thu, 03 Sep 2020 17:50:00 +0900<![CDATA[스피덱스, 네핀 병원과 바이러스성 호흡기 바이오마커 검사 대한 연방 기금 수령]]>https://www.newswire.co.kr/newsRead.php?no=910150Thu, 03 Sep 2020 17:50:00 +0900<![CDATA[SpeeDx and Roche Partner to Expand Access to Antibiotic Resistance Tests]]>https://www.newswire.co.kr/newsRead.php?no=906553Thu, 18 Jun 2020 11:40:00 +0900<![CDATA[스피덱스와 로슈, 항생제 내성 진단 확산 위해 협약 체결]]>https://www.newswire.co.kr/newsRead.php?no=906554Thu, 18 Jun 2020 11:40:00 +0900<![CDATA[스피덱스, 시리즈 B 펀딩 통해 1500만달러 추가 유치]]>https://www.newswire.co.kr/newsRead.php?no=901171Wed, 12 Feb 2020 17:53:28 +0900